Ryan Zane
Public Health & General Preventive Medicine · San Bernardino, CANPI 1669534293
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Gilead accounts for 73.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $28,488 and has fallen 80.2% since, to $5,639 in 2025. Among public health & general preventive medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $392.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$71K
- Viiv Healthcare Company$22K
- Janssen Products, LP$2K
- Johnson & Johnson$1K
- Hologic Sales And Service, LLC$48
- Janssen Scientific Affairs, LLC$19
- plus $25 from 2 others
Across 36 payments — averaging $1150.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$32K
- Viiv Healthcare Company$10K
What the payments were for
- Consulting fees$25,64026%
- Speaking & faculty fees$50,81052%
- Travel & lodging$16,30817%
- Food & beverage$4,0354%
- Education$1570%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 95 | $70,869 |
| Viiv Healthcare Company | 62 | $22,428 |
| Janssen Products, LP | 5 | $2,332 |
| Johnson & Johnson(2 entities) | 80 | $1,228 |
| Hologic Sales And Service, LLC | 2 | $48 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Alkermes, Inc. | 1 | $14 |
| Theratechnologies Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$96,950 in reported general payments places this provider in the 95th percentile of 109 public health & general preventive medicine providers in California.
See all public health & general preventive medicine providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 267 | $1,112,369 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 138 | $750,322 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 106 | $469,073 |
| PrezcobixDarunavir/Cobicistat | 121 | $336,171 |
| TivicayDolutegravir Sodium | 132 | $303,678 |
| CabenuvaCabotegravir/Rilpivirine | 38 | $252,331 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 53 | $190,323 |
| DovatoDolutegravir Sodium/Lamivudine | 60 | $185,422 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 48 | $167,626 |
| DescovyEmtricitabine/Tenofov Alafenam | 37 | $89,942 |
| IsentressRaltegravir Potassium | 19 | $41,109 |
| Darunavir | 24 | $22,170 |
| Etravirine | 12 | $12,102 |
| Valganciclovir Hcl | 11 | $2,896 |
| ValacyclovirValacyclovir Hcl | 18 | $1,005 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Descovy | $70,869 | $1,671,384410 claims |
| Viiv Healthcare CompanyTivicay, Cabenuva, Triumeq, Dovato | $22,428 | $931,754283 claims |
| Janssen Products, LPSymtuza | $2,332 | $750,322138 claims |
| Johnson & JohnsonPrezcobix | $1,228 | $336,171121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 109 public health & general preventive medicine providers in California.
Other public health & general preventive medicine in San Bernardino
- Paul KimSan Bernardino$419
- Kenneth HartSan Bernardino$297
- Erin GustafsonSan Bernardino$203
- Steven GalsonThousand Oaks$594K
- Ross MillerBeverly Hills$65K
- Daniel CosgroveIndian Wells$61K
- Philp DarneySan Francisco$13K
- Karen StuderLoma Linda$9K
- George RutherfordSan Francisco$9K
- Kate HaggertySan Marcos$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.